EBR/CLEX (EBR/CLEX)

Euronext Brussels: EBR/CLEX · EUR

€0.66

+0.00 (0.0%)· Recorded snapshot

Market cap	290.4K
Net income (ttm)	-75.7K
EPS (ttm)	-€0.17
Shares out	440K
Beta	0.89

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -75.7K
EPS (ttm): -€0.17
Market cap: 290.4K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All EBR/CLEX indicators

Market & fundamental data

Available fields

122

Groups with data

Currency

EUR

Showing 122 of 122 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2026-11-03
Enterprise value	EUR 288,890
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1956
Industry	Non-operating Establishments
Is primary listing	Yes
ISIN number	BE0003463685
Last earnings date	2025-12-24
Last refreshed	2026-10-29
Market cap	EUR 290,400
Next earnings date	2026-11-03
Price	EUR 0.66
Price currency	EUR
SIC code	9995
Stock price date	2026-10-28
Symbol	ebr/CLEX
Website	https://www.cumulex.be

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-26.08%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-1,394.02%
ROA (5Y)	-6,831.2%
ROCE	2.93%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	EUR -75,723
EPS	EUR -0.17
Gross profit	EUR -75,723
Net income	EUR -75,728
Operating income	EUR -75,723

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR -5.87
Interest coverage	-15,144.6
Long-term assets	EUR 2
Long-term liabilities	EUR 1
Net cash (debt)	EUR 1,505
Net cash / market cap	0.52%
Net cash growth	-71.5%
Piotroski F-Score	0
Shareholders' equity	EUR -2.6M
Tangible book value	EUR -2.6M
Tangible book value per share	EUR -5.87
Total assets	EUR 1,507
Total cash	EUR 1,505
Total debt	EUR 0
Total liabilities	EUR 2.6M
WACC	9.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	EUR 1,505
Current liabilities	EUR 2.6M
Current ratio	0
Net working capital	EUR -2.6M
Quick ratio	0
Working capital	EUR -2.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	19.81%
Shareholder yield	19.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-68.57%
10Y return CAGR	-10.93%
10Y total return	-68.57%
150-day SMA	EUR 0.77
15Y price change	-85.33%
15Y return CAGR	-12.01%
15Y total return	-85.33%
1D price change	0%
1M price change	-29.79%
1M total return	-29.79%
1Y price change	-11.41%
1Y return CAGR	-11.42%
1Y total return	-11.41%
20-day SMA	EUR 0.66
200-day SMA	EUR 0.76
20Y price change	-85.33%
20Y return CAGR	-9.15%
20Y total return	-85.33%
3Y price change	-67%
3Y return CAGR	-30.89%
3Y total return	-67%
50-day SMA	EUR 0.81
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 0.96
52-week high date	2026-08-27
52-week low	EUR 0.66
52-week low date	2026-10-28
5Y price change	-64.32%
5Y return CAGR	-18.63%
5Y total return	-64.32%
6M price change	-10.81%
6M total return	-10.81%
All-time high	EUR 37.00
All-time high date	2007-02-27
All-time low	EUR 0.23
All-time low date	2014-07-29
Average true range (ATR)	EUR 0.01
Average volume	19
Beta (1Y)	0.69
Beta (2Y)	0.43
Beta (5Y)	0.89
Change from 52-week high	-30.89%
Change from 52-week low	0%
Change from all-time high	-98.22%
Change from all-time low	186.96%
Monthly RSI	42.76
Previous close	EUR 0.66
Price vs 150-day SMA	-13.95%
Price vs 20-day SMA	0%
Price vs 200-day SMA	-13.33%
Price vs 50-day SMA	-18.66%
Relative volume	19.64
RSI	11.96
Sharpe ratio	-0.03
Sharpe ratio (3Y)	0.42
Sharpe ratio (5Y)	0.8
Sortino ratio	0.08
Sortino ratio (3Y)	0.81
Sortino ratio (5Y)	2.87
Weekly RSI	37.96
YTD price change	-11.41%
YTD total return	-11.41%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	64.95%
Shares change (YoY)	-19.81%
Shares outstanding	440K

Deeper analysis on EBR/CLEX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this EBR/CLEX report

Is a complete EBR/CLEX research report available?

No complete published report is available for ebr/CLEX (EBR/CLEX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EBR/CLEX (EBR/CLEX)

Euronext Brussels: EBR/CLEX · EUR

€0.66

+0.00 (0.0%)· Recorded snapshot

Market cap	290.4K
Net income (ttm)	-75.7K
EPS (ttm)	-€0.17
Shares out	440K
Beta	0.89

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -75.7K
EPS (ttm): -€0.17
Market cap: 290.4K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All EBR/CLEX indicators

Market & fundamental data

Available fields

122

Groups with data

Currency

EUR

Showing 122 of 122 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2026-11-03
Enterprise value	EUR 288,890
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1956
Industry	Non-operating Establishments
Is primary listing	Yes
ISIN number	BE0003463685
Last earnings date	2025-12-24
Last refreshed	2026-10-29
Market cap	EUR 290,400
Next earnings date	2026-11-03
Price	EUR 0.66
Price currency	EUR
SIC code	9995
Stock price date	2026-10-28
Symbol	ebr/CLEX
Website	https://www.cumulex.be

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-26.08%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-1,394.02%
ROA (5Y)	-6,831.2%
ROCE	2.93%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	EUR -75,723
EPS	EUR -0.17
Gross profit	EUR -75,723
Net income	EUR -75,728
Operating income	EUR -75,723

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR -5.87
Interest coverage	-15,144.6
Long-term assets	EUR 2
Long-term liabilities	EUR 1
Net cash (debt)	EUR 1,505
Net cash / market cap	0.52%
Net cash growth	-71.5%
Piotroski F-Score	0
Shareholders' equity	EUR -2.6M
Tangible book value	EUR -2.6M
Tangible book value per share	EUR -5.87
Total assets	EUR 1,507
Total cash	EUR 1,505
Total debt	EUR 0
Total liabilities	EUR 2.6M
WACC	9.17%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	EUR 1,505
Current liabilities	EUR 2.6M
Current ratio	0
Net working capital	EUR -2.6M
Quick ratio	0
Working capital	EUR -2.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	19.81%
Shareholder yield	19.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-68.57%
10Y return CAGR	-10.93%
10Y total return	-68.57%
150-day SMA	EUR 0.77
15Y price change	-85.33%
15Y return CAGR	-12.01%
15Y total return	-85.33%
1D price change	0%
1M price change	-29.79%
1M total return	-29.79%
1Y price change	-11.41%
1Y return CAGR	-11.42%
1Y total return	-11.41%
20-day SMA	EUR 0.66
200-day SMA	EUR 0.76
20Y price change	-85.33%
20Y return CAGR	-9.15%
20Y total return	-85.33%
3Y price change	-67%
3Y return CAGR	-30.89%
3Y total return	-67%
50-day SMA	EUR 0.81
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 0.96
52-week high date	2026-08-27
52-week low	EUR 0.66
52-week low date	2026-10-28
5Y price change	-64.32%
5Y return CAGR	-18.63%
5Y total return	-64.32%
6M price change	-10.81%
6M total return	-10.81%
All-time high	EUR 37.00
All-time high date	2007-02-27
All-time low	EUR 0.23
All-time low date	2014-07-29
Average true range (ATR)	EUR 0.01
Average volume	19
Beta (1Y)	0.69
Beta (2Y)	0.43
Beta (5Y)	0.89
Change from 52-week high	-30.89%
Change from 52-week low	0%
Change from all-time high	-98.22%
Change from all-time low	186.96%
Monthly RSI	42.76
Previous close	EUR 0.66
Price vs 150-day SMA	-13.95%
Price vs 20-day SMA	0%
Price vs 200-day SMA	-13.33%
Price vs 50-day SMA	-18.66%
Relative volume	19.64
RSI	11.96
Sharpe ratio	-0.03
Sharpe ratio (3Y)	0.42
Sharpe ratio (5Y)	0.8
Sortino ratio	0.08
Sortino ratio (3Y)	0.81
Sortino ratio (5Y)	2.87
Weekly RSI	37.96
YTD price change	-11.41%
YTD total return	-11.41%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	64.95%
Shares change (YoY)	-19.81%
Shares outstanding	440K

Deeper analysis on EBR/CLEX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this EBR/CLEX report

Is a complete EBR/CLEX research report available?

No complete published report is available for ebr/CLEX (EBR/CLEX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EBR/CLEX (EBR/CLEX)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/CLEX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/CLEX indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/CLEX

Frequently asked questions

EBR/CLEX (EBR/CLEX)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/CLEX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/CLEX indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/CLEX

Frequently asked questions